Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 5
2018 6
2019 2
2020 7
2021 7
2022 12
2023 8
2024 4
2025 6
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease.
Boskovic P, Shalita R, Gao W, Vernon H, Deng YL, Colonna M, Majzner RG, Amit I, Kipnis J. Boskovic P, et al. Among authors: majzner rg. Proc Natl Acad Sci U S A. 2026 Feb 17;123(7):e2530977123. doi: 10.1073/pnas.2530977123. Epub 2026 Feb 9. Proc Natl Acad Sci U S A. 2026. PMID: 41662521 Free PMC article.
Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapy.
Rotiroti MC, Tousley AM, Chu H, Herrera-Barrera M, Manousopoulou A, Kim WJ, Yin Y, Parish TS, Mitchell A, Holterhus M, Rysavy LW, Dalton GN, Freitas KA, Kaber G, Kropp KN, Klebanoff CA, Satpathy AT, Wang LD, Lareau CA, Majzner RG. Rotiroti MC, et al. Among authors: majzner rg. Nat Cancer. 2025 Dec;6(12):1940-1954. doi: 10.1038/s43018-025-01056-4. Epub 2025 Oct 23. Nat Cancer. 2025. PMID: 41131392 Free PMC article.
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
DuBois SG, Moreno L, Anderson J, Asgharzadeh S, Bagatell R, Beck-Popovic M, Belle J, Berlanga P, Bird NJ, Chesler L, Durbin A, Eggert A, Eilers M, Federico SM, Fischer M, Gatz SA, George RE, George S, Goldsmith KC, Gray J, Heczey A, Irwin MS, Knox L, Lode HN, Ludwinski D, Macy ME, Majzner RG, Maris JM, Modak S, Molenaar JJ, Morgenstern DA, Mossé YP, Owens C, Reynolds CP, Rossig C, Schleiermacher G, Scott L, Sondel PM, Speleman F, van Noesel M, Westermann F, Wienke J, Wolpaw AJ, Park JR, Pearson ADJ. DuBois SG, et al. Among authors: majzner rg. Pediatr Blood Cancer. 2025 Sep;72(9):e31831. doi: 10.1002/pbc.31831. Epub 2025 Jun 12. Pediatr Blood Cancer. 2025. PMID: 40509548 Review.
Immunotherapy-related cognitive impairment after CAR T cell therapy in mice.
Geraghty AC, Acosta-Alvarez L, Rotiroti MC, Dutton S, O'Dea MR, Kim W, Trivedi V, Mancusi R, Shamardani K, Malacon K, Woo PJ, Martinez-Velez N, Pham T, Reche-Ley NN, Otubu G, Castenada EH, Nwangwu K, Xu H, Mulinyawe SB, Zamler DB, Ni L, Cross K, Rustenhoven J, Kipnis J, Liddelow SA, Mackall CL, Majzner RG, Monje M. Geraghty AC, et al. Among authors: majzner rg. Cell. 2025 Jun 12;188(12):3238-3258.e25. doi: 10.1016/j.cell.2025.03.041. Epub 2025 May 12. Cell. 2025. PMID: 40359942 Free article.
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.
Domizi P, Sarno J, Jager A, Merchant M, Pacheco KZB, Yamada-Hunter SA, Rotiroti MC, Liu Y, Baskar R, Reynolds WD, Sworder BJ, Sahaf B, Bendall SC, Mullighan CG, Alizadeh AA, Leahy AB, Myers RM, Yates B, Wang HW, Shah NN, Majzner RG, Mackall CL, Grupp SA, Barrett DM, Sotillo E, Davis KL. Domizi P, et al. Among authors: majzner rg. Nat Commun. 2025 Apr 23;16(1):3800. doi: 10.1038/s41467-025-58868-2. Nat Commun. 2025. PMID: 40268897 Free PMC article.
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.
Pearson ADJ, Rossig C, Mackall CL, Shah NN, Baruchel A, Daems S, Anderson J, Biondi A, Bird N, Bodmer N, Brivio E, Buechner J, Calkoen FG, Cooper T, de Rojas T, Fox E, Gardner R, Ghorashian S, Heenen D, Ifversen M, Jacoby E, Juan M, Knox L, Komanduri K, Larghero J, Locatelli F, Ludwinski D, Majzner RG, McDonough J, Minard-Colin V, Nysom K, Pappo A, Park JR, Qasim W, Quintarelli C, Rives S, Rouce RH, Scobie N, Seitz C, Tasian SK, Weigel B, Weiner S, Zwaan CM, Vassal G. Pearson ADJ, et al. Among authors: majzner rg. Lancet Oncol. 2025 Apr;26(4):e214-e224. doi: 10.1016/S1470-2045(24)00736-8. Lancet Oncol. 2025. PMID: 40179917 Review.
Orientation-dependent CD45 inhibition with viral and engineered ligands.
Borowska MT, Liu LD, Caveney NA, Jude KM, Kim WJ, Masubuchi T, Hui E, Majzner RG, Garcia KC. Borowska MT, et al. Among authors: majzner rg. Sci Immunol. 2024 Oct 25;9(100):eadp0707. doi: 10.1126/sciimmunol.adp0707. Epub 2024 Oct 25. Sci Immunol. 2024. PMID: 39454026 Free PMC article.
Immunotherapy-related cognitive impairment after CAR T cell therapy in mice.
Geraghty AC, Acosta-Alvarez L, Rotiroti M, Dutton S, O'Dea MR, Woo PJ, Xu H, Shamardani K, Mancusi R, Ni L, Mulinyawe SB, Kim WJ, Liddelow SA, Majzner RG, Monje M. Geraghty AC, et al. Among authors: majzner rg. bioRxiv [Preprint]. 2024 May 14:2024.05.14.594163. doi: 10.1101/2024.05.14.594163. bioRxiv. 2024. Update in: Cell. 2025 Jun 12;188(12):3238-3258.e25. doi: 10.1016/j.cell.2025.03.041. PMID: 38798554 Free PMC article. Updated. Preprint.
Engineered CD47 protects T cells for enhanced antitumour immunity.
Yamada-Hunter SA, Theruvath J, McIntosh BJ, Freitas KA, Lin F, Radosevich MT, Leruste A, Dhingra S, Martinez-Velez N, Xu P, Huang J, Delaidelli A, Desai MH, Good Z, Polak R, May A, Labanieh L, Bjelajac J, Murty T, Ehlinger Z, Mount CW, Chen Y, Heitzeneder S, Marjon KD, Banuelos A, Khan O, Wasserman SL, Spiegel JY, Fernandez-Pol S, Kuo CJ, Sorensen PH, Monje M, Majzner RG, Weissman IL, Sahaf B, Sotillo E, Cochran JR, Mackall CL. Yamada-Hunter SA, et al. Among authors: majzner rg. Nature. 2024 Jun;630(8016):457-465. doi: 10.1038/s41586-024-07443-8. Epub 2024 May 15. Nature. 2024. PMID: 38750365 Free PMC article.
52 results